CAM
REGN icon

Covenant Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-387
Closed -$245K 145
2025
Q1
$245K Sell
387
-511
-57% -$324K 0.05% 125
2024
Q4
$640K Sell
898
-5,445
-86% -$3.88M 0.1% 90
2024
Q3
$6.67M Sell
6,343
-7
-0.1% -$7.36K 1.05% 19
2024
Q2
$6.67M Sell
6,350
-5
-0.1% -$5.26K 1.06% 18
2024
Q1
$6.12M Sell
6,355
-11
-0.2% -$10.6K 1% 19
2023
Q4
$5.59M Buy
6,366
+222
+4% +$195K 1% 17
2023
Q3
$5.06M Buy
6,144
+1,940
+46% +$1.6M 1.33% 16
2023
Q2
$3.02M Buy
4,204
+3,804
+951% +$2.73M 0.77% 42
2023
Q1
$329K Hold
400
0.08% 118
2022
Q4
$289K Sell
400
-28,660
-99% -$20.7M 0.07% 122
2022
Q3
$3.93M Buy
29,060
+20,572
+242% +$2.78M 1.12% 12
2022
Q2
$5.02M Sell
8,488
-3,114
-27% -$1.84M 1.59% 7
2022
Q1
$8.1M Sell
11,602
-364
-3% -$254K 2.19% 7
2021
Q4
$7.56M Sell
11,966
-13
-0.1% -$8.21K 2.01% 9
2021
Q3
$7.25M Buy
11,979
+208
+2% +$126K 2.15% 10
2021
Q2
$6.58M Buy
11,771
+10,800
+1,112% +$6.03M 1.96% 11
2021
Q1
$459K Hold
971
0.14% 103
2020
Q4
$469K Hold
971
0.15% 95
2020
Q3
$544K Hold
971
0.17% 87
2020
Q2
$606K Sell
971
-335
-26% -$209K 0.13% 78
2020
Q1
$638K Hold
1,306
0.19% 75
2019
Q4
$490K Sell
1,306
-26
-2% -$9.76K 0.21% 91
2019
Q3
$369K Sell
1,332
-234
-15% -$64.8K 0.19% 108
2019
Q2
$490K Sell
1,566
-122
-7% -$38.2K 0.25% 94
2019
Q1
$693K Buy
1,688
+792
+88% +$325K 0.36% 75
2018
Q4
$362K Hold
896
0.18% 109
2018
Q3
$362K Sell
896
-22
-2% -$8.89K 0.18% 109
2018
Q2
$317K Sell
918
-50
-5% -$17.3K 0.17% 113
2018
Q1
$333K Sell
968
-2,992
-76% -$1.03M 0.19% 107
2017
Q4
$1.49M Sell
3,960
-75
-2% -$28.2K 0.87% 44
2017
Q3
$1.8M Buy
4,035
+2
+0% +$894 1.1% 33
2017
Q2
$1.98M Sell
4,033
-23
-0.6% -$11.3K 1.27% 24
2017
Q1
$1.57M Sell
4,056
-1,296
-24% -$502K 1.06% 34
2016
Q4
$1.97M Buy
+5,352
New +$1.97M 1.32% 26